Role of animal models in HCM research

Journal of Cardiovascular Translational Research

Volumn 2, Issue 4, 2009, Pages 471-482

  Shephard, Rhian ^a   Semsarian, Christopher ^a,b,c  

^a CENTENARY INSTITUTE   (Australia)

^b ROYAL PRINCE ALFRED HOSPITAL   (Australia)

^c University of Sydney   (Australia)

Author keywords

Animal Models; Genetics; Hypertrophic Cardiomyopathy; Treatment

Indexed keywords

ACETYLCYSTEINE; ANTIARRHYTHMIC AGENT; ATORVASTATIN; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM ANTAGONIST; DILTIAZEM; MYOSIN BINDING PROTEIN C; MYOSIN HEAVY CHAIN ALPHA; MYOSIN HEAVY CHAIN BETA; SIMVASTATIN; TROPOMYOSIN; TROPONIN I; TROPONIN T;

CLINICAL FEATURE; DISEASE MARKER; DISEASE SEVERITY; GENE MUTATION; GENETIC HETEROGENEITY; HEART FAILURE; HEART MUSCLE FIBROSIS; HUMAN; HYPERTROPHIC CARDIOMYOPATHY; MEDICAL RESEARCH; MISSENSE MUTATION; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; REMISSION; REVIEW; SUDDEN DEATH; ANIMAL; CARDIOMYOPATHY, HYPERTROPHIC; CARDIOMYOPATHY, HYPERTROPHIC, FAMILIAL; COMPLICATION; DISEASE COURSE; DISEASE MODEL; GENETIC PREDISPOSITION; GENETICS; PATHOLOGY; PATHOPHYSIOLOGY; PHENOTYPE; PROGNOSIS;

ANIMALS; BIOMEDICAL RESEARCH; CARDIOMYOPATHY, HYPERTROPHIC; CARDIOMYOPATHY, HYPERTROPHIC, FAMILIAL; DISEASE MODELS, ANIMAL; DISEASE PROGRESSION; GENETIC PREDISPOSITION TO DISEASE; HUMANS; PHENOTYPE; PROGNOSIS;

ANIMALIA;

EID: 75949120576     PISSN: 19375387     EISSN: 19375395     Source Type: Journal    
DOI: 10.1007/s12265-009-9120-y     Document Type: Review

References (68)

1. C Semsarian CE Seidman 2001 Molecular medicine in the 21st century Internal Medicine Journal 31 53 59 10.1046/j.1445-5994.2001.00001.x 1:STN:280:DC%2BD38%2FisValtg%3D%3D 11478359 (Pubitemid 32411166)
2. JG Seidman C Seidman 2001 The genetic basis for cardiomyopathy: From mutation identification to mechanistic paradigms Cell 104 557 567 10.1016/S0092-8674(01)00242-2 1:CAS:528:DC%2BD3MXis1Kks70%3D 11239412 (Pubitemid 32201950)
3. P Spirito CE Seidman WJ McKenna BJ Maron 1997 The management of hypertrophic cardiomyopathy New England Journal of Medicine 336 775 785 10.1056/NEJM199703133361107 1:STN:280:DyaK2s3gtFeksA%3D%3D 9052657 (Pubitemid 27113973)
4. BJ Maron 2002 Hypertrophic cardiomyopathy: A systematic review JAMA 287 1308 1320 10.1001/jama.287.10.1308 11886323
5. JM Lind C Chiu C Semsarian 2006 Genetic basis of hypertrophic cardiomyopathy Expert Review of Cardiovascular Therapy 4 929 934 10.1586/14779072.4.6.927 (Pubitemid 46017528)
6. BJ Maron P Spirito WK Shen TS Haas F Formisano MS Link, et al. 2007 Implantable cardioverter-defibrillators and prevention of sudden cardiac death in hypertrophic cardiomyopathy JAMA 298 4 405 412 10.1001/jama.298.4.405 1:CAS:528:DC%2BD2sXot1eks7k%3D 17652294 (Pubitemid 47124061)
7. I Jayatilleke A Doolan J Ingles M McGuire V Booth DR Richmond, et al. 2004 Long-term follow-up of implantable cardioverter defibrillator therapy for hypertrophic cardiomyopathy American Journal of Cardiology 93 9 1192 1194 10.1016/j.amjcard.2004.01.057 15110224 (Pubitemid 38521061)
8. P Richard P Charron L Carrier C Ledeuil T Cheav C Pichereau, et al. 2003 Hypertrophic cardiomyopathy: Distribution of disease genes, spectrum of mutations, and implications for a molecular diagnosis strategy Circulation 107 2227 2232 10.1161/01.CIR.0000066323.15244.54 12707239 (Pubitemid 36547217)
9. H Watkins A Rosenzweig DS Hwang T Levi W McKenna CE Seidman, et al. 1992 Characteristics and prognostic implications of myosin missense mutations in familial hypertrophic cardiomyopathy New England Journal of Medicine 326 1108 1114 1:STN:280:DyaK383gsVWqsQ%3D%3D 1552912
10. AAT Geisterfer-Lowrance S Kass G Tanigawa H-P Vosberg W McKenna CE Seidman, et al. 1990 A molecular basis for familial hypertrophic cardiomyopathy: A β cardiac myosin heavy chain gene missense mutation Cell 62 999 1006 10.1016/0092-8674(90)90274-I 1:CAS:528:DyaK3cXmtVGqs7w%3D 1975517 (Pubitemid 20269146)
11. Seidman, C., & Seidman, J. G. (1995). Gene mutations that cause familial hypertrophic cardiomyopathy. In E. Haber (Ed.), Molecular cardiovascular medicine (pp. 193-210). New York: Scientific American.
12. AAT Geisterfer-Lowrance M Christe DA Conner JS Ingwall FJ Schoen CE Seidman, et al. 1996 A mouse model of familial hypertrophic cardiomyopathy Science 272 731 734 10.1126/science.272.5262.731 1:CAS:528:DyaK28Xislamtrc%3D 8614836
13. D Georgakopoulos ME Christe M Giewat CM Seidman J Seidman DA Kass 1999 The pathogenesis of familial hypertrophic cardiomyopathy: Early and evolving effects from an α-cardiac myosin heavy chain missense mutation Nature Medicine 5 327 330 10.1038/6549 1:CAS:528:DyaK1MXhsVSktrc%3D 10086390 (Pubitemid 29124370)
14. BK McConnell D Fatkin C Semsarian KA Jones D Georgakopoulos CT Maguire, et al. 2001 Comparison of two murine models of familial hypertrophic cardiomyopathy Circulation Research 88 383 389 1:CAS:528:DC%2BD3MXhs1Cqu70%3D 11230104
15. C Semsarian I Ahmad M Giewat D Georgakopoulos JP Schmitt BK McConnell, et al. 2002 The L-type calcium channel inhibitor diltiazem prevents cardiomyopathy in a mouse model Journal of Clinical Investigation 109 1013 1020 1:CAS:528:DC%2BD38XivFKjsLw%3D 11956238
16. D Fatkin ME Christe O Aristizabal BK McConnell S Srinivasan FJ Schoen, et al. 1999 Neonatal cardiomyopathy in mice homozygous for the Arg403Gln mutation in the α cardiac myosin heavy chain gene Journal of Clinical Investigation 103 147 153 10.1172/JCI4631 1:CAS:528:DyaK1MXjsl2ltg%3D%3D 9884344
17. AJ Marian Y Wu D-S Lim M McCluggage K Youker Q-T Yu, et al. 1999 A transgenic rabbit model for human hypertrophic cardiomyopathy Journal of Clinical Investigation 104 1683 1692 10.1172/JCI7956 1:CAS:528: DC%2BD3cXhtFGlsQ%3D%3D 10606622
18. SF Nagueh S Chen R Patel N Tsybouleva S Lutucuta HA Kopelen, et al. 2004 Evolution of expression of cardiac phenotypes over a 4-year period in the β-myosin heavy chain-Q403 transgenic rabbit model of human hypertrophic cardiomyopathy Journal of Molecular and Cellular Cardiology 36 663 673 10.1016/j.yjmcc.2004.02.010 1:CAS:528:DC%2BD2cXjsl2nsbw%3D 15135661 (Pubitemid 38591599)
19. R Lombardi G Rodriguez SN Chen CM Ripplinger W Li J Chen, et al. 2009 Resolution of established cardiac hypertrophy and fibrosis and prevention of systolic dysfunction in a transgenic rabbit model of human cardiomyopathy through thiol-sensitive mechanisms Circulation 119 1398 1407 10.1161/CIRCULATIONAHA.108.790501 1:CAS:528:DC%2BD1MXivVentb0%3D 19255346
20. WK Jones IL Grupp T Doetschman G Grupp H Osinska TE Hewett, et al. 1996 Ablation of the murine α myosin heavy chain gene leads to dosage effects and functional deficits in the heart Journal of Clinical Investigation 98 1906 1917 10.1172/JCI118992 1:CAS:528:DyaK28XmtlOrsLc%3D 8878443
21. S Koshida M Kurasawa M Yasuda N Sato T Obinata 1995 Assembly of cardiac C-protein during myofibrillogenesis in myogenic cells in culture Cell Structure and Function 20 253 261 10.1247/csf.20.253 1:CAS:528:DyaK2MXovFegsLs%3D 8521525
22. R Gilbert MG Kelly T Mikawa DA Fischman 1996 The carboxyl terminus of myosin binding protein C (MyBP-C, C-protein) specifies incorporation into the A-band of striated muscle Journal of Cell Science 109 101 111 1:CAS:528:DyaK28XosVahuw%3D%3D 8834795
23. H Niimura LL Bachinski S Sangwatanaroj H Watkins AE Chudley W McKenna, et al. 1998 Mutations in the gene for cardiac myosin-binding protein C and late-onset familial hypertrophic cardiomyopathy New England Journal of Medicine 338 1248 1257 10.1056/NEJM199804303381802 1:CAS:528:DyaK1cXivF2qtrY%3D 9562578 (Pubitemid 28216578)
24. G Bonne L Carrier P Richard B Hainque K Schwartz 1998 Familial hypertrophic cardiomyopathy: From mutations to functional defects Circulation Research 83 580 593 1:CAS:528:DyaK1cXmt1Knt7w%3D 9742053 (Pubitemid 28427741)
25. H Watkins D Conner L Thierfelder JA Jarcho C MacRae WJ McKenna, et al. 1995 Mutations in the cardiac myosin binding protein-C gene on chromosome 11 cause familial hypertrophic cardiomyopathy Nature Genetics 11 434 437 10.1038/ng1295-434 1:CAS:528:DyaK2MXpvVCksb4%3D 7493025
26. BK McConnell KA Jones D Fatkin LH Arroyo RT Lee O Aristizabal, et al. 1999 Dilated cardiomyopathy in homozygous myosin-binding protein-C mutant mice Journal of Clinical Investigation 104 1235 1244 10.1172/JCI7377 1:CAS:528:DyaK1MXntVOgsrk%3D 10545522
27. M Kelly C Semsarian 2009 Multiple mutations in genetic cardiovascular disease: A marker of disease severity? Circulation: Cardiovascular Genetics 2 182 190 10.1161/CIRCGENETICS.108.836478 1:CAS:528:DC%2BD1MXmvVyhtrc%3D
28. SP Harris CR Bartley TA Hacker KS McDonald PS Douglas ML Greaser, et al. 2002 Hypertrophic cardiomyopathy in cardiac myosin binding protein-C knockout mice Circulation Research 90 594 601 10.1161/01.RES.0000012222.70819.64 1:CAS:528:DC%2BD38XisFWlsLo%3D 11909824 (Pubitemid 34640910)
29. L Carrier R Knöll N Vignier DI Keller P Bausero B Prudhon, et al. 2004 Asymmetric septal hypertrophy in heterozygous cMyBP-C null mice Cardiovascular Research 63 293 304 10.1016/j.cardiores.2004.04.009 1:CAS:528:DC%2BD2cXlsFymu78%3D 15249187 (Pubitemid 38900843)
30. L Thierfelder H Watkins C MacRae R Lamas W McKenna H-P Vosberg, et al. 1994 α-Tropomyosin and cardiac troponin T mutations cause familial hypertrophic cardiomyopathy: A disease of the sarcomere Cell 77 701 712 10.1016/0092-8674(94)90054-X 8205619
31. H Watkins WJ McKenna L Thierfelder HJ Suk R Anan A O'Donoghue, et al. 1995 Mutations in the genes for cardiac troponin T and α-tropomyosin in hypertrophic cardiomyopathy New England Journal of Medicine 332 1058 1064 10.1056/NEJM199504203321603 1:CAS:528:DyaK2MXlslCnsrw%3D 7898523
32. JC Moolman VA Corfield B Posen K Ngumbela C Seidman PA Brink, et al. 1997 Sudden death due to troponin T mutations Journal of the American College of Cardiology 29 549 555 10.1016/S0735-1097(96)00530-X 1:STN:280: DyaK2s3hsVGisA%3D%3D 9060892 (Pubitemid 27116096)
33. JC Tardiff SM Factor BD Tompkins TE Hewett BM Palmer RL Moore, et al. 1998 A truncated cardiac troponin T molecule in transgenic mice suggests multiple cellular mechanisms for familial hypertrophic cardiomyopathy Journal of Clinical Investigation 101 2800 2811 10.1172/JCI2389 1:CAS:528: DyaK1cXktVSiu78%3D 9637714
34. N Frey WM Franz K Gloeckner M Degenhardt M Müller O Müller, et al. 2000 Transgenic rat hearts expressing a human cardiac troponin T deletion reveal diastolic dysfunction and ventricular arrhythmias Cardiovascular Research 47 254 264 10.1016/S0008-6363(00)00114-0 1:CAS:528:DC%2BD3cXlsFChsbg%3D 10946062 (Pubitemid 30625288)
35. M Luedde U Flögel M Knorr C Grundt H-J Hippe B Brors, et al. 2009 Decreased contractility due to energy deprivation in a transgenic rat model of hypertrophic cardiomyopathy Journal of Molecular Medicine 87 411 422 10.1007/s00109-008-0436-x 1:CAS:528:DC%2BD1MXktFCitbs%3D 19189074
36. M Luedde U Flogel M Knorr C Grundt HJ Hippe B Brors, et al. 2009 Decreased contractility due to energy deprivation in a transgenic rat model of hypertrophic cardiomyopathy Journal of Molecular Medicine 87 4 411 422 10.1007/s00109-008-0436-x 1:CAS:528:DC%2BD1MXktFCitbs%3D 19189074
37. MM Javadpour JC Tardiff I Pinz JS Ingwall 2003 Decreased energetics in murine hearts bearing the R92Q mutation in cardiac troponin T Journal of Clinical Investigation 112 768 775 1:CAS:528:DC%2BD3sXntlSiu70%3D 12952925
38. A Kimura PJ-E Haruhito H Nishi M Satoh M Takahashi, et al. 1997 Mutations in the cardiac troponin I gene associated with hypertrophic cardiomyopathy Nature Genetics 16 379 382 10.1038/ng0897-379 1:CAS:528:DyaK2sXkvFChtrk%3D 9241277 (Pubitemid 27323305)
39. A Doolan M Tebo J Ingles L Nguyen T Tsoutsman L Lam, et al. 2005 Cardiac troponin I mutations in Australian families with hypertrophic cardiomyopathy: Clinical, genetic and functional consequences Journal of Molecular and Cellular Cardiology 38 2 387 393 10.1016/j.yjmcc.2004.12.006 1:CAS:528: DC%2BD2MXhtFGrs7o%3D 15698845 (Pubitemid 40215208)
40. J James Y Zhang H Osinska A Sanbe R Klevitsky TE Hewett, et al. 2000 Transgenic modeling of a cardiac troponin I mutation linked to familial hypertrophic cardiomyopathy Circulation Research 87 805 811 1:CAS:528: DC%2BD3cXnvVOlu7Y%3D 11055985 (Pubitemid 30813011)
41. A Sanbe J James V Tuzcu S Nas L Martin J Gulick, et al. 2005 Transgenic rabbit model for human troponin I-based hypertrophic cardiomyopathy Circulation 111 2330 2338 10.1161/01.CIR.0000164234.24957.75 1:CAS:528:DC%2BD2MXjsl2itr8%3D 15867176 (Pubitemid 40647069)
42. T Tsoutsman J Chung A Doolan L Nguyen IA Williams E Tu, et al. 2006 Molecular insights from a novel cardiac troponin I mouse model of familial hypertrophic cardiomyopathy Journal of Molecular and Cellular Cardiology 41 623 632 10.1016/j.yjmcc.2006.07.016 1:CAS:528:DC%2BD28Xps1OksL0%3D 16950368 (Pubitemid 44374544)
43. AJ Marian R Roberts 1998 Molecular genetic basis of hypertrophic cardiomyopathy: Genetic markers for sudden cardiac death Journal of Cardiovascular Electrophysiology 9 88 99 10.1111/j.1540-8167.1998.tb00871.x 1:STN:280:DyaK1c7jtlOhuw%3D%3D 9475582
44. DA Coviello BJ Maron P Spirito H Watkins H-P Vosberg L Thierfelder, et al. 1997 Clinical features of hypertrophic cardiomyopathy caused by mutation of a "hot spot" in the alpha-tropomyosin gene Journal of the American College of Cardiology 29 635 640 10.1016/S0735-1097(96)00538-4 1:STN:280:DyaK2s3hsVGhtg%3D%3D 9060904 (Pubitemid 27116108)
45. M Muthuchamy K Pieples P Rethinasamy B Hoit IL Grupp GP Boivin, et al. 1999 Mouse model of a familial hypertrophic cardiomyopathy mutation in α-tropomyosin manifests cardiac dysfunction Circulation Research 85 47 56 1:CAS:528:DyaK1MXktlOhu7s%3D 10400910
46. R Prabhakar GP Boivin IL Grupp B Hoit G Arteaga RJ Solaro, et al. 2001 A familial hypertrophic cardiomyopathy α-tropomyosin mutation causes severe cardiac hypertrophy and death in mice Journal of Molecular and Cellular Cardiology 33 1815 1828 10.1006/jmcc.2001.1445 1:CAS:528:DC%2BD3MXnsFOjtrw%3D 11603924 (Pubitemid 32977135)
47. R Prabhakar N Petrashevskaya A Schwartz B Aronow GP Boivin JD Molkentin, et al. 2003 A mouse model of familial hypertrophic cardiomyopathy caused by a α-tropomyosin mutation Molecular and Cellular Biochemistry 251 33 42 10.1023/A:1025409227350 1:CAS:528:DC%2BD3sXovFCgtLc%3D 14575301 (Pubitemid 37220706)
48. E Kremneva S Boussouf O Nikolaeva R Maytum MA Geeves DI Levitsky 2004 Effects of two familial hypertrophic cardiomyopathy mutations in α-tropomyosin, Asp175Asn and Glu180Gly, on the thermal unfolding of actin-bound tropomyosin Biophysical Journal 87 3922 3933 10.1529/biophysj.104. 048793 1:CAS:528:DC%2BD2cXhtVOmtbnK 15454401 (Pubitemid 39602898)
49. R Fries AM Heaney KM Meurs 2008 Prevalence of the myosin-binding protein C mutation in Maine Coon cats Journal of Veterinary Internal Medicine 22 893 896 10.1111/j.1939-1676.2008.0113.x 1:STN:280:DC%2BD1cvmvVWgsg%3D%3D 18498321 (Pubitemid 352039171)
50. MD Kittleson KM Meurs MJ Munro JA Kittleson S-K Liu PD Pion, et al. 1999 Familial hypertrophic cardiomyopathy in Maine Coon cats: An animal model of human disease Circulation 99 3172 3180 1:STN:280:DyaK1MzgslSltg%3D%3D 10377082
51. A Sakamoto K Ono M Abe G Jasmin T Eki Y Murakami, et al. 1997 Both hypertrophic and dilated cardiomyopathies are caused by mutation of the same gene, δ-sarcoglycan, in hamster: An animal model of disrupted dystrophin-associated glycoprotein complex Proceedings of the National Academy of Sciences of the United States of America 94 13873 13878 10.1073/pnas.94.25. 13873 1:CAS:528:DyaK2sXotVart7c%3D 9391120 (Pubitemid 28009677)
52. S Lowey LM Lesko AS Rovner AR Hodges SL White RB Low, et al. 2008 Functional effects of the hypertrophic cardiomyopathy R403Q mutation are different in an α- or β-myosin heavy chain backbone Journal of Biological Chemistry 283 20579 20589 10.1074/jbc.M800554200 1:CAS:528: DC%2BD1cXotlOhs7g%3D 18480046
53. P Robinson PJ Griffiths H Watkins CS Redwood 2007 Dilated and hypertrophic cardiomyopathy mutations in troponin and α-tropomyosin have opposing effects on the calcium affinity of cardiac thin filaments Circulation Research 101 1266 1273 10.1161/CIRCRESAHA.107.156380 1:CAS:528: DC%2BD2sXhtlOjsLzK 17932326 (Pubitemid 350294643)
54. M Tyska E Hayes M Giewat C Seidman J Seidman D Warshaw 2000 Single-molecular mechanisms of R403Q cardiac isolated from the mouse model of familial hypertrophic cardiomyopathy Circulation Research 86 737 744 1:CAS:528:DC%2BD3cXislyns78%3D 10764406
55. 2+ response in mutant sarcomere protein-mediated familial hypertrophic cardiomyopathy Journal of Clinical Investigation 106 1351 1359 10.1172/JCI11093 1:CAS:528:DC%2BD3cXosFKlsLs%3D 11104788
56. V Senthil SN Chen N Tsybouleva T Halder SF Nagueh JT Willerson, et al. 2005 Prevention of cardiac hypertrophy by atorvastatin in a transgenic rabbit model of human hypertrophic cardiomyopathy Circulation Research 97 285 292 10.1161/01.RES.0000177090.07296.ac 1:CAS:528:DC%2BD2MXmslelt7c%3D 16020756 (Pubitemid 41105455)
57. JP Konhilas LA Leinwand 2007 The effects of biological sex and diet on the development of heart failure Circulation 116 23 2747 2759 10.1161/CIRCULATIONAHA.106.672006 18056540 (Pubitemid 350291247)
58. SW Luckey J Mansoori K Fair CL Antos EN Olson LA Leinwand 2007 Blocking cardiac growth in hypertrophic cardiomyopathy induces cardiac dysfunction and decreased survival only in males American Journal of Physiology. Heart and Circulatory Physiology 292 2 H838 H845 10.1152/ajpheart.00615.2006 1:CAS:528:DC%2BD2sXjt1GnsLc%3D 17012357 (Pubitemid 46246933)
59. BL Stauffer JP Konhilas ED Luczak LA Leinwand 2006 Soy diet worsens heart disease in mice Journal of Clinical Investigation 116 1 209 216 10.1172/JCI24676 1:CAS:528:DC%2BD28XjslOgsw%3D%3D 16395406 (Pubitemid 43121806)
60. LA Leinwand 2003 Sex is a potent modifier of the cardiovascular system Journal of Clinical Investigation 112 3 302 307 1:CAS:528:DC%2BD3sXmtFemsLc%3D 12897194
61. C Semsarian MJ Healey D Fatkin M Giewat C Duffy CE Seidman, et al. 2001 A polymorphic modifier gene alters the hypertrophic response in a murine model of familial hypertrophic cardiomyopathy Journal of Molecular and Cellular Cardiology 33 2055 2060 10.1006/jmcc.2001.1466 1:CAS:528:DC%2BD3MXot12gsL8%3D 11708849 (Pubitemid 33097283)
62. A Doolan L Nguyen C Semsarian 2004 Hypertrophic cardiomyopathy: from "heart tumour" to a complex molecular genetic disorder Heart, Lung and Circulation 13 15 25 10.1016/j.hlc.2004.01.026 1:CAS:528:DC%2BD2MXit1WmsL4%3D 16352163 (Pubitemid 40903138)
63. D Westermann BC Knollmann P Steendijk S Rutschow A Riad M Pauschinger, et al. 2006 Diltiazem treatment prevents diastolic heart failure in mice with familial hypertrophic cardiomyopathy European Journal of Heart Failure 8 115 121 10.1016/j.ejheart.2005.07.012 1:CAS:528:DC%2BD28XhsFOju7Y%3D 16214409 (Pubitemid 43240843)
64. R Patel SF Nagueh N Tsybouleva M Abdellatif S Lutucuta HA Kopelen, et al. 2001 Simvastatin induces regression of cardiac hypertrophy and fibrosis and improves cardiac function in a transgenic rabbit model of human hypertrophic cardiomyopathy Circulation 104 317 324 10.1161/hc2801.094031 1:CAS:528:DC%2BD3MXlslOmtL0%3D 11457751
65. J Bauersachs S Störk M Kung C Waller F Fidler C Hoyer, et al. 2007 HMG CoA reductase inhibition and left ventricular mass in hypertrophic cardiomyopathy: A randomized placebo-controlled pilot study European Journal of Clinical Investigation 37 852 859 10.1111/j.1365-2362.2007.01877.x 1:CAS:528:DC%2BD2sXhsVSrtr3O 17973781 (Pubitemid 350029212)
66. J Ingles A Doolan C Chiu J Seidman C Seidman C Semsarian 2005 Compound and double mutations in patients with hypertrophic cardiomyopathy: Implications for genetic testing and counselling Journal of Medical Genetics 42 10 59 10.1136/jmg.2005.033886
67. SL Van Driest SR Ommen AJ Tajik BJ Gersh MJ Ackerman 2005 Sarcomeric genotyping in hypertrophic cardiomyopathy Mayo Clinic Proceedings 80 4 463 469 10.4065/80.4.463 15819282
68. T Tsoutsman M Kelly D Ng J-E Tan E Tu L Lam, et al. 2008 Severe heart failure and early mortality in a double-mutation mouse model of familial hypertrophic cardiomyopathy Circulation 117 1820 1831 10.1161/CIRCULATIONAHA. 107.755777 18362229